SEC Tracker
Get the app
LITS · XBRL financial data

Lite Strategy financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (LITS's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue65,297000*0000*————
Research and development3,4853,9125,2203,944*3,16330836983*10463036*
General and administrative6,5318,0184,6094,137*5,1893,1432,4052,795*3,0983,3052,7352,909*
Other operating income (expense)—————(2,677)(2,573)——(30,799)(23,694)—
Operating income (loss)55,281(11,930)(9,829)(18,980)*(8,352)(3,451)(2,774)(2,878)*(3,739)(29,867)(21,610)(11,361)*
Other income (expense)(1)(2)(4)(34)*(10)(5)(1)0*0000*
Income tax expense (benefit)———year only———year only———year only
Net income (loss)56,374(11,063)(9,127)(18,406)*(8,007)(2,677)(2,573)(2,688)*(3,639)(30,799)(23,694)(13,018)*
Earnings per share, basic USD per share8.46(1.66)(1.37)(2.76)*(1.20)(0.40)(0.39)(0.40)*(0.12)(0.82)(0.66)(0.36)*
Earnings per share, diluted USD per share8.46(1.66)(1.37)(2.76)*(1.20)(0.40)(0.39)(0.40)*(0.12)(0.82)(0.66)(0.36)*
Weighted average shares, basic thousands of shares6,6636,6636,6636,663*6,6636,6636,6636,663*29,47537,37235,71135,716*
Weighted average shares, diluted thousands of shares6,6636,6636,6636,663*6,6636,6636,6636,663*29,47537,37235,71135,716*

Balance sheet

CSV

Fiscal quarters (LITS's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents3,3725,1742,3683,7056,95223,73920,47218,01110,1138,7587,5445,706
Short-term investments78,83054,30654,18434,64019,953000————
Accounts receivable00000000————
Prepaid and other current assets6,2206,6922,8142,4248406463072743,1232,1541,347435
Total current assets88,42266,17259,36640,76927,74524,38520,77918,28513,23610,91210,9756,141
Property and equipment, net1,2291,1441,0583925000————
Right-of-use asset11,60011,22210,8362140000————
Total assets101,25178,53871,26041,37527,75024,38520,77918,285113,33782,93757,78942,692
Accounts payable3,2201,3783,1763,168976596177176503327253261
Accrued liabilities4,2895,6455,3885,1871,8961,6911,0611,178565760699808
Total current liabilities8,5648,0389,6168,3552,8722,2871,2381,3541,0681,0879521,069
Lease liability, non-current11,32611,01210,6150————————
Total liabilities19,89019,05020,2318,3552,8722,2871,2381,3541,0681,0879521,069
Accumulated deficit(349,623)(360,686)(369,813)(388,219)(396,226)(398,903)(401,476)(404,164)(407,803)(438,602)(462,296)(475,314)
Total stockholders' equity81,36159,48851,02933,02024,87822,09819,54116,931112,26981,85056,83741,623
Total liabilities and equity101,25178,53871,26041,37527,75024,38520,77918,285113,33782,93757,78942,692
Common shares outstanding (cover page) thousands of shares6,6636,6636,6636,6636,6636,6636,66335,65536,78536,36234,02530,407

Cash flows

CSV

Fiscal quarters (LITS's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)56,374(11,063)(9,127)(18,406)*(8,007)(2,677)(2,573)(2,688)*(3,639)(30,799)(23,694)(13,018)*
Stock-based compensation363850668397*(135)(103)1678*284234*270*500*
Depreciation and amortization8785*86*125*3680*0*0*00*0*0*
Net cash from operating activities(18,491)(11,055)*(2,928)*(17,999)*(11,450)(3,666)*(3,267)*(2,461)*(4,508)(1,929)*(1,520)*(1,164)*
Purchases of property and equipment07*0*0*——0*0*————
Net cash from investing activities4,95724,517*122*19,544*14,69720,453*0*0*(100,000)569*2,098*2,226*
Proceeds from issuing common stock————00*0*0*4,411217*0*0*
Share repurchases——————0*0*——1,792*2,900*
Dividends paid——0*0*——0*0*————
Net cash from financing activities0(11,660)*0*(208)*00*0*0*96,6105*(1,792)*(2,900)*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Lite Strategy5,706not reported(1,164)*30.4M4.9 quarters 10-KJun 30, 2026
Actinium Pharmaceuticals36,47335,000(5,179)*31.4M7.0 quarters 10-QJun 30, 2026
Fortress Biotech196,57618,718(59,277)*33.3M3.3 quarters 10-QJun 30, 2026
Actuate Therapeutics4,426not reported(4,405)*24.0M1.0 quarters 10-QJun 30, 2026
Acumen Pharmaceuticals53,075not reported(26,653)*72.3M3.4 quarters 10-QSep 30, 2026
Opus Genetics88,812755(11,950)*83.2M7.4 quarters 10-QJun 30, 2026
CervoMed22,4630(6,918)*15.1M3.6 quarters 10-QJun 30, 2026
Precision Biosciences81,6980(15,132)*27.9M6.1 quarters 10-QSep 30, 2026
Atara Biotherapeutics3,221630(3,338)*10.0M3.0 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.